{"keywords":["Concomitant","Echinoderm microtubule-associated protein-like 4","Epidermal growth factor receptor","NSCLC","Tyrosine kinase inhibitor"],"meshTags":["Adenocarcinoma","Drug Resistance, Neoplasm","Female","Humans","Lung Neoplasms","Middle Aged","Mutation","Oncogene Proteins, Fusion","Protein Kinase Inhibitors","Receptor Protein-Tyrosine Kinases","Receptor, Epidermal Growth Factor"],"meshMinor":["Adenocarcinoma","Drug Resistance, Neoplasm","Female","Humans","Lung Neoplasms","Middle Aged","Mutation","Oncogene Proteins, Fusion","Protein Kinase Inhibitors","Receptor Protein-Tyrosine Kinases","Receptor, Epidermal Growth Factor"],"genes":["EGFR","EML4","ALK","tyrosine kinase"],"publicationTypes":["Case Reports","Journal Article","Research Support, Non-U.S. Gov\u0027t","Review"],"title":"Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.","pubmedId":"25496960"}